Results 191 to 200 of about 48,035 (283)
Abstract Background Malnutrition is common among patients with decompensated liver cirrhosis and linked to poor prognosis. Guidelines recommend intensified nutrition support e.g. parenteral nutrition, but evidence regarding safety and effectiveness is scarce. We aimed to investigate the impact of nutrition support, specifically parenteral nutrition, on
Katharina L. Hupa‐Breier +10 more
wiley +1 more source
Higher sun exposure is associated with a reduced risk of primary biliary cholangitis. [PDF]
French J +7 more
europepmc +1 more source
Abstract Cystic biliary atresia (CBA) is a rare variant of biliary atresia that closely resembles choledochal cyst (CC), complicating diagnosis and potentially delaying critical surgical intervention. We report two cases of CBA that were difficult to diagnose.
Hamza Hassan Khan +2 more
wiley +1 more source
A multifaceted analysis of OTUD5 integrated MAVS in innate immunity of Primary Biliary Cholangitis. [PDF]
Chen R, Sun Y, Tai W.
europepmc +1 more source
Abstract Pancreatic and biliary tract injuries from blunt abdominal trauma are rare in children. Common bile duct (CBD) strictures secondary to pancreatic trauma are even more uncommon, and management traditionally involves surgery. We report a 9‐year‐old boy who developed a severe distal intrapancreatic CBD stricture after blunt pancreatic trauma ...
Alexis M. Woida +2 more
wiley +1 more source
Human leukocyte antigen variants and clinical features of primary biliary cholangitis: Cumulative contributions. [PDF]
Bouayad A.
europepmc +1 more source
Splenic artery aneurysms occurring in liver transplant recipients [PDF]
Bronsther, O +3 more
core +1 more source
Liver Fibrosis: Molecular Pathogenesis and Therapeutic Interventions
We systematically summarized the etiologies, diagnostic approaches, and pathogenic mechanisms of liver fibrosis. Also, the therapeutic interventions for liver fibrosis were systematically classified into two main categories: etiological treatment and mechanism‐based antifibrotic therapies.
Jiaorong Qu +8 more
wiley +1 more source
Ocular surface characteristics and dry eye symptoms in primary biliary cholangitis patients complicated with seasonal allergic conjunctivitis. [PDF]
Ruan F +5 more
europepmc +1 more source
ABSTRACT Elafibranor 80 mg/day is approved for second‐line primary biliary cholangitis (PBC) treatment. We present pharmacokinetic (PK) analyses of elafibranor and its metabolite, GFT1007, and pharmacokinetic‐pharmacodynamic (PKPD) analyses describing the relationship between their exposure and responses in alkaline phosphatase (ALP) and total ...
Qing Xi Ooi +5 more
wiley +1 more source

